Jean Klastersky
Jean Klastersky
1Institut Jules Bordet, 1000 Brussels, Belgium; Department of Medicine, Centre Hospitalier Universitaire Vaudois, 1011 Lausanne, Switzerland; University of Maryland Cancer Center, Baltimore, Maryland 21201; Division of Infectious Diseases, Roger Williams General Hospital, Brown University, Providence, Rhode Island 02908; and Microbiology Department, Brompton Hospital, London SW3 6HP, England
1,
Michel P Glauser
Michel P Glauser
1Institut Jules Bordet, 1000 Brussels, Belgium; Department of Medicine, Centre Hospitalier Universitaire Vaudois, 1011 Lausanne, Switzerland; University of Maryland Cancer Center, Baltimore, Maryland 21201; Division of Infectious Diseases, Roger Williams General Hospital, Brown University, Providence, Rhode Island 02908; and Microbiology Department, Brompton Hospital, London SW3 6HP, England
1,
Stephen C Schimpff
Stephen C Schimpff
1Institut Jules Bordet, 1000 Brussels, Belgium; Department of Medicine, Centre Hospitalier Universitaire Vaudois, 1011 Lausanne, Switzerland; University of Maryland Cancer Center, Baltimore, Maryland 21201; Division of Infectious Diseases, Roger Williams General Hospital, Brown University, Providence, Rhode Island 02908; and Microbiology Department, Brompton Hospital, London SW3 6HP, England
1,
Stephen H Zinner
Stephen H Zinner
1Institut Jules Bordet, 1000 Brussels, Belgium; Department of Medicine, Centre Hospitalier Universitaire Vaudois, 1011 Lausanne, Switzerland; University of Maryland Cancer Center, Baltimore, Maryland 21201; Division of Infectious Diseases, Roger Williams General Hospital, Brown University, Providence, Rhode Island 02908; and Microbiology Department, Brompton Hospital, London SW3 6HP, England
1,
Harold Gaya
Harold Gaya
1Institut Jules Bordet, 1000 Brussels, Belgium; Department of Medicine, Centre Hospitalier Universitaire Vaudois, 1011 Lausanne, Switzerland; University of Maryland Cancer Center, Baltimore, Maryland 21201; Division of Infectious Diseases, Roger Williams General Hospital, Brown University, Providence, Rhode Island 02908; and Microbiology Department, Brompton Hospital, London SW3 6HP, England
1;
The European Organization for Research on Treatment of Cancer Antimicrobial Therapy Project Group1
1Institut Jules Bordet, 1000 Brussels, Belgium; Department of Medicine, Centre Hospitalier Universitaire Vaudois, 1011 Lausanne, Switzerland; University of Maryland Cancer Center, Baltimore, Maryland 21201; Division of Infectious Diseases, Roger Williams General Hospital, Brown University, Providence, Rhode Island 02908; and Microbiology Department, Brompton Hospital, London SW3 6HP, England